Aviado · Research
Longevity Daily
Sunday, May 24, 2026
Listen
Today's Brief
Today's most important story challenges a supplement millions of health optimizers take daily: new research in Nature Metabolism suggests NAD+ blood levels don't actually decline with age, undermining the core rationale for NMN and NR. A second major evidence check from The BMJ finds routine calcium and vitamin D fail to protect most older adults from falls. On the research front, a 45,000-person UK Biobank study reveals that your eyes may be the most accessible window into your biological age, while Lifespan.io covers a mitochondrial lipid most longevity protocols have never addressed.
10 stories3 peer-reviewed1 trials
Cognitive Health & Neuroprotection
Florida Researchers Show Lifestyle Choices Can Speed or Slow Brain Aging — Independent of Body Age
University of Florida researchers are advancing the concept of "brain age" as distinct from both chronological age and body age, demonstrating that daily lifestyle choices directly accelerate or decelerate the brain's biological clock. Their work contributes to a growing field attempting to reverse organ-specific aging through targeted behavioral and clinical interventions. The consumer takeaway is direct: what you eat, how you sleep, and how much you move today may be reshaping the pace of your brain's aging in measurable ways.
Read more →Supplements & Compounds
NAD+ Blood Levels Don't Fall With Age, New Nature Metabolism Study Finds — Upending the Case for Supplements
A study published in Nature Metabolism challenges the foundational premise behind the booming NAD+ supplement market: blood levels of NAD+ do not actually decline with age as the industry has long claimed. The New York Times report details how celebrities, influencers, and millions of health-conscious consumers have been spending $50–$100/month on NMN and NR supplements based on this now-questioned assumption. While tissue-level NAD+ dynamics still warrant investigation and the researchers aren't declaring the supplements useless, this is a significant credibility blow to the category. If NAD+ precursors are in your stack, this is the most important read of the week.
Read more →Daily Calcium and Vitamin D Don't Prevent Falls in Most Older Adults, Major BMJ Study Concludes
A major new study in The BMJ finds that routine calcium and vitamin D supplementation does not reduce falls or fractures in the majority of older adults — directly challenging one of the most widely recommended supplement protocols for aging populations. The findings add to a growing body of evidence questioning blanket supplementation in people without documented deficiency. If you or a family member is taking these supplements primarily for fall prevention, the evidence now suggests a conversation with your doctor is warranted.
Read more →Research & Papers
Mitochondria Age Faster When a Key Membrane Lipid Disappears — And Supplementing It Helped
Scientists have identified that phosphatidylcholine — the most abundant lipid in mitochondrial membranes — declines with age in worms, and that this decline actively drives mitochondrial dysfunction. Supplementing with the lipid reversed some of these effects in vitro. This is early-stage research (worms and cell cultures), but it points to a potentially underexplored supplementation target for anyone focused on mitochondrial health.
Read more →Your Eye Exam May Be the Best Biomarker of Your Biological Age, 45,000-Person Study Suggests
Researchers analyzed data from 45,819 UK Biobank participants and built a "multimodal ocular aging index" (MOAI) integrating eye phenotypes with plasma proteomics and metabolomics using machine learning. Over nearly 14 years of follow-up, accelerated ocular aging predicted significantly higher risk of age-related macular degeneration and cataract — beyond traditional risk factors — with systemic inflammation identified as the primary driver. The finding suggests that your eye health isn't just local: it may be one of the clearest readouts of how fast your body as a whole is aging.
Read more →A New Class of Anti-Aging Drugs Targets Senescent 'Zombie' Cells — Here's Where the Science Stands
Dermatology Times surveys the emerging landscape of senotherapeutics — drugs designed to either eliminate senescent cells (senolytics) or suppress their inflammatory activity without killing them (senomorphics). Compounds under active investigation include navitoclax and compounds from AbbVie, targeting survival pathways like p53 and p21. Most candidates are still years from approved anti-aging use, but for anyone tracking the next wave of longevity medicine, this is a useful clinical primer on what's in the pipeline.
Read more →Skin May Be the Most Accessible Window Into How Fast You're Aging Systemically
A GeroScience review makes the case that the skin — as the body's largest, most environmentally exposed, and most directly observable organ — is uniquely positioned to serve as both a biomarker and a testing platform for systemic aging interventions. Hallmarks of aging visible in skin, including cellular senescence, mitochondrial dysfunction, and epigenetic changes, closely mirror what's happening throughout the body. The authors argue that clinicians and researchers should use skin assessments to personalize and track anti-aging treatment responses — a practical reframe for an organ often treated as superficial.
Read more →Lifestyle & Nutrition
Changing Your Diet Can Shift Your Biological Age Clock by Several Years, Research Review Finds
The latest Fight Aging! newsletter highlights research showing that dietary changes can measurably shift scores on the Klemera-Doubal aging clock — one of the more validated biological age calculators — by a meaningful margin of several years. The edition also covers findings that inhibiting the integrated stress response slows aging in flies. For anyone tracking biological age metrics, the takeaway is that food choices remain one of the highest-leverage, lowest-cost interventions available.
Read more →Why You Respond Differently to Strength Training Than Your Gym Partner: New Science on Individual Variation
A summary paper from the 2025 International Conference on Resistance Training Response Heterogeneity finds that age, pre-training molecular signatures, and specific training variables all significantly influence individual muscle-building outcomes. Practical findings: weekly volume, rest interval duration, and training proximity to failure meaningfully affect hypertrophy for most people, while exercise selection is more flexible than often assumed. If your resistance training program isn't delivering expected results, this emerging science suggests the explanation may be biological — not a lack of effort.
Read more →Industry & Policy
Rapamycin for Muscle Aging Trial Is $320,000 Short of Its Funding Goal — and the Field Needs It
New Zealand physician Dr. Brad Stanfield's clinical trial on rapamycin's effects on aging muscle has raised only $30,000 of the $350,000+ needed to proceed. The trial is one of the few human studies designed specifically to test rapamycin's impact on muscle aging and physical function — a critical data gap given that virtually all longevity evidence for rapamycin comes from animal models. The community forum post notes the funding shortfall but also highlights broader momentum: over 29 independent labs have confirmed lifespan improvements with rapamycin in animal studies.
Read more →